Jointown Pharmaceutical Group Co., Ltd
SSE:600998.SS
5.45 (CNY) • At close June 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 151,809.799 | 150,139.847 | 140,424.192 | 122,407.434 | 110,859.514 | 99,497.077 | 87,136.359 | 73,942.894 | 61,556.84 | 49,589.246 | 41,068.404 | 33,438.05 | 29,507.663 | 24,838.679 | 21,251.773 | 18,957.709 | 16,287.598 | 13,048.103 |
| Cost of Revenue
| 139,967.716 | 138,028.963 | 129,476.178 | 112,569.808 | 100,919.393 | 90,794.651 | 79,614.267 | 67,705.533 | 56,732.6 | 45,834.442 | 38,152.978 | 31,208.384 | 27,616.925 | 23,334.825 | 19,874.881 | 17,801.515 | 15,368.963 | 12,389.351 |
| Gross Profit
| 11,842.083 | 12,110.884 | 10,948.013 | 9,837.626 | 9,940.121 | 8,702.426 | 7,522.091 | 6,237.361 | 4,824.24 | 3,754.804 | 2,915.427 | 2,229.666 | 1,890.738 | 1,503.854 | 1,376.892 | 1,156.194 | 918.636 | 658.751 |
| Gross Profit Ratio
| 0.078 | 0.081 | 0.078 | 0.08 | 0.09 | 0.087 | 0.086 | 0.084 | 0.078 | 0.076 | 0.071 | 0.067 | 0.064 | 0.061 | 0.065 | 0.061 | 0.056 | 0.05 |
| Reseach & Development Expenses
| 146.702 | 196.605 | 178.392 | 194.942 | 126.626 | 74.132 | 76.233 | 19.065 | 11.426 | 11.634 | 11.825 | 12.24 | 15.227 | 8.978 | 3.113 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,297.283 | 1,320.418 | 828.303 | 800.801 | 636.017 | 588.668 | 532.046 | 493.427 | 348.202 | 287.483 | 200.554 | 145.353 | 108.554 | 85.443 | 66.041 | 311.018 | 247.891 | 170.542 |
| Selling & Marketing Expenses
| 1,917.408 | 1,983.521 | 4,126.105 | 3,674.038 | 3,541.897 | 3,135.261 | 2,818.305 | 2,276.445 | 1,633.434 | 1,225.702 | 1,062.305 | 789.264 | 678.648 | 546.376 | 457.422 | 379.038 | 316.78 | 225.294 |
| SG&A
| 3,214.691 | 7,324.86 | 4,954.408 | 4,474.839 | 4,177.914 | 3,723.929 | 3,350.351 | 2,769.871 | 1,981.637 | 1,513.185 | 1,262.859 | 934.617 | 787.202 | 631.819 | 523.463 | 690.056 | 564.671 | 395.835 |
| Other Expenses
| 4,845.642 | 1,455.894 | 1,819.139 | 1,691.248 | 1,556.508 | 1,407.202 | 4.756 | -20.734 | 62.732 | 96.322 | 112.947 | 94.767 | 60.253 | 140.347 | 33.546 | 20.431 | 9.841 | 5.568 |
| Operating Expenses
| 8,207.035 | 8,977.36 | 6,951.939 | 6,361.029 | 5,861.049 | 5,205.262 | 4,823.866 | 4,016.335 | 3,031.647 | 2,380.764 | 1,892.457 | 1,395.863 | 1,192.015 | 973.869 | 807.582 | 721.275 | 585.402 | 408.286 |
| Operating Income
| 3,635.048 | 3,022.718 | 4,359.079 | 3,592.627 | 4,352.38 | 3,625.507 | 1,829.954 | 1,941.558 | 1,049.161 | 859.978 | 641.544 | 513.306 | 492.812 | 349.993 | 439.25 | 358.082 | 254.701 | 197.146 |
| Operating Income Ratio
| 0.024 | 0.02 | 0.031 | 0.029 | 0.039 | 0.036 | 0.021 | 0.026 | 0.017 | 0.017 | 0.016 | 0.015 | 0.017 | 0.014 | 0.021 | 0.019 | 0.016 | 0.015 |
| Total Other Income Expenses Net
| 2.421 | -31.855 | -1,520.992 | -229.363 | -18.362 | -1,308.059 | 0.848 | -16.947 | -594.017 | 95.834 | 111.837 | 93.471 | -138.901 | 136.337 | 33.4 | -49.117 | -61.139 | -42.881 |
| Income Before Tax
| 3,637.469 | 2,990.863 | 2,838.087 | 3,363.264 | 4,334.018 | 2,317.448 | 1,830.802 | 1,924.732 | 1,105.649 | 955.812 | 753.38 | 606.777 | 552.451 | 489.648 | 471.983 | 377.546 | 263.867 | 202.467 |
| Income Before Tax Ratio
| 0.024 | 0.02 | 0.02 | 0.027 | 0.039 | 0.023 | 0.021 | 0.026 | 0.018 | 0.019 | 0.018 | 0.018 | 0.019 | 0.02 | 0.022 | 0.02 | 0.016 | 0.016 |
| Income Tax Expense
| 851.03 | 701.202 | 552.554 | 754.882 | 948.936 | 535.965 | 449.33 | 451.816 | 201.308 | 251.942 | 185.111 | 135.898 | 139.847 | 114.089 | 111.722 | 73.761 | 61.207 | 43.038 |
| Net Income
| 2,507.392 | 2,174.043 | 2,084.963 | 2,448.334 | 3,075.055 | 1,726.549 | 1,340.579 | 1,445.51 | 876.742 | 694.535 | 560.707 | 477.928 | 412.721 | 374.134 | 353.427 | 297.892 | 202.636 | 159.783 |
| Net Income Ratio
| 0.017 | 0.014 | 0.015 | 0.02 | 0.028 | 0.017 | 0.015 | 0.02 | 0.014 | 0.014 | 0.014 | 0.014 | 0.014 | 0.015 | 0.017 | 0.016 | 0.012 | 0.012 |
| EPS
| 0.5 | 0.43 | 0.53 | 0.63 | 0.79 | 0.44 | 0.49 | 0.58 | 0.36 | 0.29 | 0.24 | 0.23 | 0.19 | 0.17 | 0.18 | 0.17 | 0.11 | 0.23 |
| EPS Diluted
| 0.5 | 0.43 | 0.51 | 0.63 | 0.74 | 0.4 | 0.48 | 0.57 | 0.36 | 0.29 | 0.24 | 0.23 | 0.19 | 0.17 | 0.18 | 0.17 | 0.11 | 0.23 |
| EBITDA
| 5,765.149 | 5,083.446 | 4,716.012 | 5,164.401 | 5,924.741 | 4,054.956 | 3,123.056 | 2,605.021 | 2,061.661 | 1,742.673 | 1,357.757 | 1,141.907 | 984.522 | 781.034 | 707.121 | 469.34 | 404.459 | 301.881 |
| EBITDA Ratio
| 0.038 | 0.034 | 0.034 | 0.042 | 0.053 | 0.041 | 0.036 | 0.035 | 0.033 | 0.035 | 0.033 | 0.034 | 0.033 | 0.031 | 0.033 | 0.025 | 0.025 | 0.023 |